Medicare Advantage

Health care stocks including UnitedHealth Group, Inc. (NYSE:UNH), Elevance Health, Inc. (NYSE:ELV) and CVS Health Corp. (NYSE:CVS) are tanking in Wednesday's extended trading after the Centers for Medicare & Medicaid Services (CMS) announced a significant expansion of its auditing efforts for...

UnitedHealth Group Inc. (NYSE:UNH) shares were down by more than 21% Thursday, the stock's worst drop since 1998, after the company reported worse-than-expected quarterly results due in part to the rising cost of health care in the U.S. CEO Andrew Witty provided additional insights on the company's...

Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the...

This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week. AMTD Digital: Asian digital solutions platform AMTD Digital (NYSE: HKD) offers risk solutions and digital...

UnitedHealth Group Inc. (NYSE: UNH) hosted an investor day Tuesday highlighting the company’s growth, special technologies and 2019 guidance. The Analysts Morgan Stanley analyst Zack Sopcak reiterated an Overweight rating on UnitedHealth and $308 price target. Wells Fargo analyst Peter Costa...

Analysts at Citi initiates coverage of Aetna Inc (NYSE: AET) with a Buy rating, $180 price target and named to the firm's "Citi Focus List." Aetna should be viewed as a "strong diversified health insurer" that is also well positioned to gain share within the government segment and has "stable...

Argus in a note released on Friday upgraded shares of Humana Inc (NYSE: HUM), with the upgrade premised on the belief that the company has strong growth prospects as an independent company following the termination of its merger agreement with Aetna Inc (NYSE: AET). The Annulled Deal Aetna...

The mega-merger between Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM) was officially called off Tuesday morning, although this shouldn't come as a surprise after a ruling from the U.S. District Court for the District of Columbia declined the transaction. A joint press release from the two...

The Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM) deal hangs in limbo as John Bates, the Federal Judge appointed to oversee the case is yet to give a timeline for the final ruling even after the final hearing is over. The deadline, which has been pushed forward twice, now looms large, with...

While questions and uncertainties persist regarding healthcare companies' prospects in the wake of an Affordable Care Act repeal, let's look ahead to what is in store for the impending merger between Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM). Merger Deal Announced After a Wall Street...

Humana Inc (NYSE: HUM) shareholders are watching and waiting patiently for a federal judge to determine the fate of the proposed mega-merger between Humana and Aetna Inc (NYSE: AET). The U.S. Department of Justice filed suit to block the merger on antitrust grounds, and both sides presented closing...

Although President-elect Donald Trump's victory spells higher chances for the regulatory approval of the $37 billion merger between Aetna Inc (NYSE: AET) and Humana Inc (NYSE: HUM), the antitrust suit on the deal amplifies the difficulty the firms face in trying to get the nod of approval from...

Donald Trump’s victory and the “Republican sweep of Congress” could have a significantly greater impact on equity values than the initial share price moves, Credit Suisse’s Scott Fidel said in a report. He added that the outlook for the Diversified MCO [Managed Care...